Thursday, January 30, 2014
6:00 pm - 9:00 pm THU 1/30
Speakers
Gary Cohen, Executive Vice President, BD (Becton, Dickinson and Company); Chairman, CDC Foundation
Thomas Frieden, Director, U.S. Centers for Disease Control and Prevention
Johnny Isakson, U.S. Senator, Georgia
Michael Klowden, CEO, Milken Institute
Michael Milken, Chairman, Milken Institute
Friday, January 31, 2014
7:30 am - 8:45 am FRI 1/31
8:55 am - 9:10 am FRI 1/31
Speakers
Thomas Frieden, Director, U.S. Centers for Disease Control and Prevention
Michael Milken, Chairman, Milken Institute
9:10 am - 10:05 am FRI 1/31
Today, a health threat anywhere is a threat everywhere. New microbes emerge and spread quickly with international trade and travel. Drug resistance is increasing, and bioterrorism could strike any nation. In all of these scenarios, CDC is America's front line of defense. This panel will explore how the agency does its crucial work and also feature clips from the movie "Contagion," which tracks the course of a devastating global outbreak through the eyes of CDC disease detectives. While the script is fiction, it reflects very real risks. There were 50-100 million deaths worldwide from the 1918 flu pandemic, and new and rapidly changing strains of flu pose a similar threat today. Yet, a future pandemic could do more than devastate our nation's health. It could also jeopardize the bonds that hold our society together and cause lasting economic damage.
Moderator
Gary Cohen, Executive Vice President, BD (Becton, Dickinson and Company); Chairman, CDC Foundation
Speakers
Larry Brilliant, President and CEO, Skoll Global Threats Fund
Ali Khan, U.S. Assistant Surgeon General (Ret.); Director, Office of Public Health Preparedness and Response, CDC
Anne Schuchat, U.S. Assistant Surgeon General; Director, National Center for Immunization and Respiratory Diseases, CDC
10:15 am - 11:00 am FRI 1/31
This session provides an open forum for members of Congress, senior executives and major philanthropists to discuss the public health issues that affect their constituents, their companies, their causes and the nation's health. Mike Milken and Tom Frieden will lead the discussion.
Speakers
Sanford D. Bishop Jr., U.S. Representative, Georgia
Vincent Forlenza , Chairman, CEO and President, BD (Becton, Dickinson and Company)
Thomas Frieden, Director, U.S. Centers for Disease Control and Prevention
Robert Hugin, CEO and Chairman, Celgene; Chairman, PhRMA
Jack Kingston, U.S. Representative, Georgia
Michael Milken, Chairman, Milken Institute
Sue Siegel, CEO, healthymagination, GE
10:15 am - 11:00 am FRI 1/31
For more than a century, America's universities and charitable foundations have been at the forefront of innovations that increased quality of life and extended longevity. Today more than ever, the nonprofit sector plays a crucial role in improving public health in the nation and around the world. But philanthropies, universities, and public charities vary greatly in their cultures, views, and capacity to effect meaningful change. So how can these disparate organizations coordinate their efforts for the greater good? That's the art of alignment. We'll examine how the most successful philanthropies and universities find common ground to change the world.
Moderator
Charles Stokes, President and CEO, CDC Foundation
Speakers
Anna Barker, Director, Transformative Healthcare Networks, and Co-Director, Complex Adaptive Systems Initiative, Arizona State University
Lynn Goldman, Dean, School of Public Health and Health Services, George Washington University
Larry Jameson, Executive Vice President, University of Pennsylvania for the Health System; Dean, University of Pennsylvania Medical School
John Lange, Senior Fellow, Global Health Diplomacy, United Nations Foundation; Former U.S. Ambassador to Botswana
James Marks, Senior Vice President, Robert Wood Johnson Foundation
11:10 am - 12:05 pm FRI 1/31
No one should go to the doctor to get well and instead get a life-threatening infection, but one in every 20 hospitalized patients contracts an infection caused by medical care, resulting in 99,000 deaths and up to $45 billion in excess medical costs each year. Likewise, Americans count on a safe food supply, but CDC estimates that 48 million people get sick and 3,000 die from contaminated food annually with costs up to $77 billion. And antibiotics are miracle drugs that most of us rely on, but bacteria are devising new ways to outsmart them, as in the case of drug-resistant tuberculosis. Breakthroughs in advanced molecular detection (AMD) are rendering these and other challenges imminently more solvable. Not long ago, it took months to sequence - and months more to interpret - a tiny part of a genome. Now, through AMD, a microchip can do all of this in a matter of hours. How do we harness scientific advances to address these national and global health challenges that result from bio-terror, bio-error and newly emerging superbugs?
Moderator
Larry Brilliant, President and CEO, Skoll Global Threats Fund
Speakers
Beth Bell, Director of the National Center for Emerging and Zoonotic Infectious Diseases, CDC
Victoria Nahum, Executive Director, Safe Care Campaign
Lance Price, Professor, Environmental and Occupational Health, School of Public Health and Health Services, George Washington University
Andrew von Eschenbach, President, Samaritan Health Initiatives; former Commissioner, U.S. Food and Drug Administration; former Director, National Cancer Institute
12:15 pm - 12:30 pm FRI 1/31
Speaker
Charles Stokes, President and CEO, CDC Foundation
12:50 pm - 2:00 pm FRI 1/31
The public health ecosystem includes pharmaceutical and biotechnology companies, academic medical research centers, major charitable foundations, local and state health departments, the World Health Organization, NGOs, schools of public health, national health agencies around the world and, at its very center, the U.S. Centers for Disease Control and Prevention. Not one of these entities can achieve its mission independent of the others. It is a complex and highly effective web of dedicated scientists who stand between all of us and global disaster. The experts on this panel will explore how to make that web even more effective and efficient, so that the past century's remarkable advances in health and longevity continue for future generations.
Moderator
Michael Milken, Chairman, Milken Institute
Introduction By
Charles Stokes, President and CEO, CDC Foundation
Speakers
Thomas Frieden, Director, U.S. Centers for Disease Control and Prevention
Freda Lewis-Hall, Executive Vice President and Chief Medical Officer, Pfizer, Inc.
Trevor Mundel, President, Global Health Program, Bill & Melinda Gates Foundation
Carmen Puliafito, Dean, Keck School of Medicine, University of Southern California
Judith Rodin, President, The Rockefeller Foundation
2:10 pm - 3:00 pm FRI 1/31
CDC is America's 9-1-1 responder to health security threats. When the call comes in, members of the elite Epidemic Intelligence Service (EIS) ship out at a moment's notice to wherever they're needed - from Bakersfield to Botswana to Bhutan. Whether applied to an infectious disease, deliberate attack or other emergency, CDC's expertise in preparedness, rapid detection and response saves lives and safeguards the world. Indeed, the agency's most important achievements are the outbreaks that didn't happen and the diseases that were stopped before they crossed our borders. Those lives protected often can't be counted, and they don't make the news. Nor do the stories of the brave men and women who carry out that work. You'll hear them today.
Moderator
Michael Bell, Deputy Director, Division of Healthcare Quality Promotion, CDC
Speakers
Robyn Neblett Fanfair, Epidemiologist, CDC
Andrea McCollum, Epidemiologist, CDC
Jennifer McQuiston, Veterinary Medical Officer, CDC
Tyler Sharp, Epidemiologist, CDC
Rachel Smith, Medical Epidemiologist, CDC
2:10 pm - 3:00 pm FRI 1/31
Most analyses of chronic illness focus on direct medical expenses, but that approach shows only a small part of the picture. Missing are the drag on long-term economic growth and the impact on productivity (largely through absenteeism and "presenteeism," in which employees show up but underperform). In 2007, the Milken Institute took a comprehensive view in "An Unhealthy America," which forecast the economic benefits the nation could reap by "containing the containable" costs of seven common chronic diseases. By midcentury, the report estimated, the U.S. economy could be $5.7 trillion smaller if we don't change course. In conjunction with this Summit, the Institute re-ran the numbers to determine whether we're making progress. Chief Research Officer Ross DeVol joins a panel focused on strategies that communities, businesses and nonprofits are implementing to create a healthier America.
Moderator
Margaret Anderson, Executive Director, FasterCures
Speakers
Steve Burd, CEO, Burd and Company; Former Chairman and CEO, Safeway Inc.
Ross DeVol, Chief Research Officer, Milken Institute
David Heber, Professor and Director, UCLA Center for Human Nutrition
Kenneth Thorpe, Chairman, Emory Partnership to Fight Chronic Disease; Professor and Chair, Department of Health Policy and Management, Emory University
3:10 pm - 3:55 pm FRI 1/31
The doubling of life expectancy globally during the 20th century is perhaps the greatest achievement of our civilization. Improved health has reduced suffering immeasurably, and it accounts for an estimated half of all economic growth since 1900. Public health programs to ensure clean water and food, minimize the impact of pandemics and improve vehicle safety have played vital roles. Corporate wellness programs have also resulted in a healthier, more productive workforce that uses less sick leave and is more likely to stay employed. Companies and other organizations that have implemented effective wellness programs have collectively saved billions of dollars in health expenses while reducing costs of recruitment and training. Just returning the American population to its average weight of two decades ago could save at least $1 trillion a year. This panel will discuss what has worked and why.
Moderator
Michael Milken, Chairman, Milken Institute
Speakers
Steve Burd, CEO, Burd and Company; Former Chairman and CEO, Safeway Inc.
Robert Hugin, CEO and Chairman, Celgene; Chairman, PhRMA
Rajiv Kaul, Portfolio Manager, Select Biotechnology Portfolio and Advisor Biotechnology Fund, Fidelity Investments
Mehmood Khan, Executive Vice President and Chief Scientific Officer, Global Research and Development, PepsiCo
Judith Monroe, Director, Office for State, Tribal, Local, and Territorial Support, CDC
3:55 pm - 4:10 pm FRI 1/31
Speakers
Thomas Frieden, Director, U.S. Centers for Disease Control and Prevention
Michael Milken, Chairman, Milken Institute
4:15 pm - 5:00 pm FRI 1/31
4:15 pm - 5:00 pm FRI 1/31